Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$36.9M
91M shares
52-week range
$0.22 – $0.60
55% from low
Sector
ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
Exchange
XASE
CS
P/S (TTM)
4.2
Milestone Scientific Inc develops and commercializes proprietary computer-controlled drug delivery systems designed to enhance the safety, precision, and patient experience associated with subcutaneous injections and fluid aspiration procedures. The company's core technology platform, Dynamic Pressure Sensing (DPS) Technology, controls flow rate and measures pressure at the needle tip in real time. DPS Technology is incorporated into both the company's dental and medical products and supports clinical applications, including local anesthesia delivery, epidural space identification in regional anesthesia procedures, and intra-articular joint injections. It operates in two segments: Dental, which markets and sells its dental products, and Medical, markets and sells its medical products.
www.milestonescientific.comNo one on the platform currently holds MLSS.
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 82,497 | $23.8K |
| Execution date | Ratio |
|---|---|
| 2004-01-14 | 1-for-3reverse |
No one on the platform has traded MLSS yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Analyst estimates unavailable for this ticker.
$MLSS Not sure what contract you are referring to..When a new account is added it becomes a revenue source immediately upon issuing or signing an agreement to purchase product..
View on StockTwits ↗$MLSS Painman (or anybody else more knowledgeable than me), just because we sign up an account, does that guarantee sales / revenue? Or is it contract dependent?
View on StockTwits ↗$MLSS Maybe this is why we were up after hours??? Not going to claim I understand it completely..... https://s3.amazonaws.com/sec.irpass.cc/2675/0001493152-26-043419.htm
View on StockTwits ↗$MLSS I'm already looking forward to the next big announcement. Start stringing some additional revenue inducing news together. Even the most jaded and slow cannot ignore multiple big sales.
View on StockTwits ↗$MLSS loaded more and put in another order to scoop up discounted shares
View on StockTwits ↗$MLSS same short Scumbag dumping at the bell.Nice AH rebound!
View on StockTwits ↗$MLSS You can plainly see how they mark it down at the close. I alerted IR today to pass on this development to management. If you want to own stock buy market on close and you should get the best price. Amazing how many scumbags are in the marketplace.
View on StockTwits ↗$MLSS Nice little news drop on $MLSS today Dr Rao & PSS specialists as development advisors. PASS has 22 clinic locations across MD, PA, VA and FL so getting CompuFlo in there is huge for real world usage Main takeaway for me is high volume practice = steady disposable cassette orders, plus it builds up the clinical data they need for CPT Cat I reimbursement down the road
View on StockTwits ↗$MLSS Well nothing like Great News to bring in the short seller.. news today is extremely bullish.
View on StockTwits ↗$MLSS So that means a sale of at 22 boxes and probably at least 20,000 procedures a year..Probably double that..HUGE deal.
View on StockTwits ↗$MLSS news just out that a leading doctor for a spine co. practice has joined the company. Not earth shattering but is good.
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $10M | +8.2% | $-0.04 | $-0.04–$-0.04 | — | 2 |
| 2027 | $11M | +13.8% | $-0.04 | $-0.04–$-0.03 | — | 2 |
| 2028 | $14M | +23.7% | $-0.02 | $-0.02–$-0.02 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 3 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-08-13 | $-0.01 | $-0.01 | +0.0% |
| 2026-05-13 | $-0.01 | $-0.01 | +33.3% |
| 2026-03-31 | $-0.01 | $-0.02 | -33.3% |
| 2025-11-13 | $-0.01 | $-0.01 | +33.3% |
| 2025-08-14 | $-0.01 | $-0.02 | -100.0% |
| 2025-05-15 | $-0.01 | $-0.02 | -100.0% |
| 2025-03-28 | $-0.01 | $-0.03 | -155.1% |
| 2024-11-14 | $-0.01 | $-0.02 | -100.0% |
| $35M |
| — |
| MYOMyomo, Inc. | $1.48 | +11.28% | $57M | — |
| NTRBNutriband Inc. | $8.13 | +6.27% | $99M | — |
Source: Financial Modeling Prep · peers by sector/industry